Recent studies have identified elevated expression of SOAT1 and increased cholesteryl ester content in various cancer types, including glioma, pancreatic cancer, prostate cancer, lung cancer, and adrenocortical carcinoma [17–22]. This evidence concerns the gene SOAT1 and prostate carcinoma.